TRANSLATIONAL NEUROSCIENCE.

Area 2 is made up of 6 research lines, with one group per line. Its general objectives are the design, synthesis and characterisation of new compounds with potential neuroprotection effects in neurodegenerative disease and cerebrovascular accidents; the search for biomarkers for early diagnosis, the study of disease progression and treatment response; the characterisation of drugs in preclinical trials in animal models and in human clinical trials; and the expansion of knowledge of affective disorders in the population, studying risk factors, clinical evolution and treatment response, with the aim of improving the population’s mental health.